Plasma and brain pharmacokinetic parameters determined by noncompartmental analysis after the administration of a single intravenous bolus dose of sorafenib in wild-type mice
The ratio of AUC in the brain to that in plasma was estimated to be 0.06, signifying the restricted brain penetration of sorafenib.